Chief Executive Officer
D. Carl Long co-founded NeuroTrauma Sciences in July 2016 and serves as the company’s Chief Executive Officer. He has more than 30 years of finance and operating experience in various fields, including the pharmaceutical and medical device industries, and has been part of the founding management team of several early stage companies. As a global investor and financier, Carl’s expertise includes organizational management, financing strategies, venture capital, and the creation of shareholder value through execution of effective exit strategies. Carl’s previous positions in life sciences included Co-Founder and President of Flouromed Pharmaceuticals and Co-Founder, Executive Vice President and Director of Alliance Pharmaceuticals, where he assisted leading the company to a successful IPO and towards building a world-class Research and Development management team. In addition, he served as President, Chief Executive Officer and Vice Chairman of Biofield Corp., a medical device company he also co-founded and assisted in bringing to a successful IPO. Carl studied medicine at the Royal College of Surgeons in Dublin, Ireland and the University of Michigan Medical School, Ann Arbor, in addition to spending five years at University of California, San Diego Medical Center and University of Nice, France conducting research in flourocarbon-based oxygen delivery therapeutics and cancer diagnostics.